Regulus Therapeutics Stock Price on October 19, 2024
| RGLS Stock | USD 1.63 0.02 1.24% |
Below is the normalized historical share price chart for Regulus Therapeutics extending back to October 04, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Regulus Therapeutics stands at 1.63, as last reported on the 3rd of December, with the highest price reaching 1.66 and the lowest price hitting 1.59 during the day.
If you're considering investing in Regulus Stock, it is important to understand the factors that can impact its price. Currently, Regulus Therapeutics is very risky. Regulus Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of 0.0272, which implies the firm had a 0.0272% return per unit of risk over the last 3 months. We have found thirty technical indicators for Regulus Therapeutics, which you can use to evaluate the volatility of the company. Please check Regulus Therapeutics' Coefficient Of Variation of 6302.7, semi deviation of 3.86, and Risk Adjusted Performance of 0.0203 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%.
At this time, Regulus Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 19.9 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 29.2 M in 2024. . At this time, Regulus Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.07 in 2024, whereas Price Earnings Ratio is likely to drop (0.85) in 2024. Regulus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of October 2012 | 200 Day MA 1.8786 | 50 Day MA 1.528 | Beta 1.628 |
Regulus |
Sharpe Ratio = 0.0272
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | RGLS | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.1 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Regulus Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Regulus Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.23 | Enterprise Value Ebitda 0.5691 | Price Sales 7.4299 | Shares Float 42.4 M | Wall Street Target Price 10.3333 |
Regulus Therapeutics Main Headline on 18th of October 2024
Acquisition by Witz Pascale of 90000 shares of Regulus Thera... by Witz Pascale
Filed transaction by Regulus Therapeutics Director. Grant, award or other acquisition pursuant to Rule 16b-3
Regulus Therapeutics Valuation on October 19, 2024
It is possible to determine the worth of Regulus Therapeutics on a given historical date. On October 19, 2024 Regulus was worth 1.53 at the beginning of the trading date compared to the closed value of 1.57. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Regulus Therapeutics stock. Still, in general, we apply an absolute valuation method to find Regulus Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regulus Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Regulus Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 1.59 | 1.60 | 1.52 | 1.52 | 124,346 | |
10/18/2024 | 1.53 | 1.64 | 1.52 | 1.57 | 222,902 |
| 1.58 | 1.65 | 1.49 | 1.50 | 574,287 |
| Backtest Regulus Therapeutics | | | Regulus Therapeutics History | | | Regulus Therapeutics Valuation | Previous | Next |
Regulus Therapeutics Trading Date Momentum on October 19, 2024
| On October 21 2024 Regulus Therapeutics was traded for 1.50 at the closing time. The top price for the day was 1.65 and the lowest listed price was 1.49 . The trading volume for the day was 574.3 K. The trading history from October 21, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 4.46% . The trading delta at closing time against the current closing price is 7.01% . |
Regulus Therapeutics Fundamentals Correlations and Trends
By evaluating Regulus Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Regulus Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Regulus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Regulus Therapeutics Stock history
Regulus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Regulus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Regulus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Regulus Therapeutics stock prices may prove useful in developing a viable investing in Regulus Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 19 M | 19.9 M | |
| Net Loss | -32.6 M | -34.2 M |
Regulus Therapeutics Quarterly Net Working Capital |
|
Regulus Therapeutics Stock Technical Analysis
Regulus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Regulus Therapeutics Period Price Range
Low | December 3, 2024
| High |
0.00 | 0.00 |
Regulus Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Regulus Therapeutics December 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Regulus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Regulus Therapeutics shares will generate the highest return on investment. By undertsting and applying Regulus Therapeutics stock market strength indicators, traders can identify Regulus Therapeutics entry and exit signals to maximize returns
Regulus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Regulus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Regulus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Regulus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0203 | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.56) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0596 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Regulus Stock Analysis
When running Regulus Therapeutics' price analysis, check to measure Regulus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regulus Therapeutics is operating at the current time. Most of Regulus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Regulus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regulus Therapeutics' price. Additionally, you may evaluate how the addition of Regulus Therapeutics to your portfolios can decrease your overall portfolio volatility.